Downregulation of the tyrosine degradation pathway extends Drosophila lifespan

  1. Andrey A Parkhitko  Is a corresponding author
  2. Divya Ramesh
  3. Lin Wang
  4. Dmitry Leshchiner
  5. Elizabeth Filine
  6. Richard Binari
  7. Abby L Olsen
  8. John M Asara
  9. Valentin Cracan
  10. Joshua D Rabinowitz
  11. Axel Brockmann
  12. Norbert Perrimon  Is a corresponding author
  1. Harvard Medical School, United States
  2. National Centre for Biological Sciences, India
  3. Lewis-Sigler Institute for Integrative Genomics, Princeton University, United States
  4. Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, United States
  5. Beth Israel Deaconess Medical Center, United States
  6. Scintillon Institute, United States
  7. Princeton University, United States

Abstract

Aging is characterized by extensive metabolic reprogramming. To identify metabolic pathways associated with aging, we analyzed age-dependent changes in the metabolomes of long-lived Drosophila melanogaster. Among the metabolites that changed, levels of tyrosine were increased with age in long-lived flies. We demonstrate that the levels of enzymes in the tyrosine degradation pathway increase with age in wild-type flies. Whole-body and neuronal-specific downregulation of enzymes in the tyrosine degradation pathway significantly extends Drosophila lifespan, causes alterations of metabolites associated with increased lifespan, and upregulates the levels of tyrosine-derived neuromediators. Moreover, feeding wild-type flies with tyrosine increased their lifespan. Mechanistically, we show that suppression of ETC complex I drives the upregulation of enzymes in the tyrosine degradation pathway, an effect that can be rescued by tigecycline, an FDA-approved drug that specifically suppresses mitochondrial translation. In addition, tyrosine supplementation partially rescued lifespan of flies with ETC complex I suppression. Altogether, our study highlights the tyrosine degradation pathway as a regulator of longevity.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Additional metabolomics data are available upon request.

The following previously published data sets were used

Article and author information

Author details

  1. Andrey A Parkhitko

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    For correspondence
    aparkhitko@genetics.med.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9852-8329
  2. Divya Ramesh

    Tata Institute of Fundamental Research, National Centre for Biological Sciences, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1387-7832
  3. Lin Wang

    Department of Chemistry, Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Dmitry Leshchiner

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Elizabeth Filine

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Richard Binari

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Abby L Olsen

    Department of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. John M Asara

    Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Valentin Cracan

    Department of Chemistry, Scintillon Institute, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Joshua D Rabinowitz

    Department of Chemistry, Princeton University, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Axel Brockmann

    Tata Institute of Fundamental Research, National Centre for Biological Sciences, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
  12. Norbert Perrimon

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    For correspondence
    perrimon@receptor.med.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7542-472X

Funding

NIA (K99/R00 AG057792)

  • Andrey A Parkhitko

NIH (5P01CA120964)

  • Norbert Perrimon

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Parkhitko et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Andrey A Parkhitko
  2. Divya Ramesh
  3. Lin Wang
  4. Dmitry Leshchiner
  5. Elizabeth Filine
  6. Richard Binari
  7. Abby L Olsen
  8. John M Asara
  9. Valentin Cracan
  10. Joshua D Rabinowitz
  11. Axel Brockmann
  12. Norbert Perrimon
(2020)
Downregulation of the tyrosine degradation pathway extends Drosophila lifespan
eLife 9:e58053.
https://doi.org/10.7554/eLife.58053

Share this article

https://doi.org/10.7554/eLife.58053

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Iti Mehta, Jacob B Hogins ... Larry Reitzer
    Research Article

    Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.

    1. Genetics and Genomics
    Yi Li, Long Gong ... Shangbang Gao
    Research Article

    Resistance to anthelmintics, particularly the macrocyclic lactone ivermectin (IVM), presents a substantial global challenge for parasite control. We found that the functional loss of an evolutionarily conserved E3 ubiquitin ligase, UBR-1, leads to IVM resistance in Caenorhabditis elegans. Multiple IVM-inhibiting activities, including viability, body size, pharyngeal pumping, and locomotion, were significantly ameliorated in various ubr-1 mutants. Interestingly, exogenous application of glutamate induces IVM resistance in wild-type animals. The sensitivity of all IVM-affected phenotypes of ubr-1 is restored by eliminating proteins associated with glutamate metabolism or signaling: GOT-1, a transaminase that converts aspartate to glutamate, and EAT-4, a vesicular glutamate transporter. We demonstrated that IVM-targeted GluCls (glutamate-gated chloride channels) are downregulated and that the IVM-mediated inhibition of serotonin-activated pharynx Ca2+ activity is diminished in ubr-1. Additionally, enhancing glutamate uptake in ubr-1 mutants through ceftriaxone completely restored their IVM sensitivity. Therefore, UBR-1 deficiency-mediated aberrant glutamate signaling leads to ivermectin resistance in C. elegans.